OSBORNE DAVID W - Insider Non-Derivative Transactions at Arcutis Biotherapeutics, Inc. (ARQT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 6, 2023, OSBORNE DAVID W's relationship to Arcutis Biotherapeutics, Inc. (ARQT) is Officer (Chief Technical Officer), and currently has 268,854 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ARQT insiders.
Data Source: SEC.
OSBORNE DAVID W - Insider Non-Derivative Transactions of ARQT Common Stock
OSBORNE DAVID W - Insider Non-Derivative Transactions at ARQT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 7, 2023 | Sell -- (Common Stock) | 690 | 15.26 | 268854 |
| Mar 3, 2023 | Sell -- (Common Stock) | 15 | 16.52 | 254644 |
| Mar 3, 2023 | Sell -- (Common Stock) | 1198 | 15.82 | 254659 |
| Mar 3, 2023 | Acquisition -- (Common Stock) | 14900 | 0 | 269544 |
| Mar 1, 2023 | Sell -- (Common Stock) | 792 | 16.17 | 255857 |